Ten CMC Questions for Emerging Biotechs in 2025
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Ten CMC Questions for Emerging Biotechs in 2025
-
Narrated by:
-
By:
About this listen
This podcast presents ten crucial questions for emerging biotech companies to consider when reviewing their Chemistry, Manufacturing, and Controls (CMC) strategies at year-end. The questions cover various aspects, including regulatory milestones, data analytics, risk management, quality assurance, and future goals. Each question includes examples illustrating its importance for successful drug development. The ultimate aim is to ensure a robust CMC strategy aligned with regulatory expectations and industry best practices, thereby minimizing delays and maximizing the chances of successful submissions. Failing to address these questions could result in significant setbacks.
Support the show
adbl_web_global_use_to_activate_webcro805_stickypopup
No reviews yet